Pediatric Osteoporosis: Revision of Diagnostic and Therapeutic Aspects

Authors

  • Helena Reis Costa Interna Complementar de Medicina Física e de Reabilitação; Serviço de Fisiatria do Centro Hospitalar do Porto – Hospital de Santo António; Porto, Portugal
  • Maria Miguel Ribeiro Interna Complementar de Medicina Física e de Reabilitação; Serviço de Fisiatria do Centro Hospitalar do Porto – Hospital de Santo António; Porto, Portugal
  • Susana Marques Interna Complementar de Medicina Física e de Reabilitação; Serviço de Fisiatria do Centro Hospitalar do Porto – Hospital de Santo António; Porto, Portugal
  • Helena Castro Interna Complementar de Medicina Física e de Reabilitação; Serviço de Fisiatria do Centro Hospitalar do Porto – Hospital de Santo António; Porto, Portugal
  • Lurdes Palhau Assistente Hospitalar Graduada de Medicina Física e de Reabilitação; Directora do Serviço de Fisiatria do Centro Hospitalar do Porto – Hospital de Santo António; Porto, Portugal

DOI:

https://doi.org/10.25759/spmfr.50

Abstract

Paediatric osteoporosis (PO) can be primary or secondary to chronic diseases or medications. This second grouphas been increasing recently and capturing attention from the scientific community.PO is usually asymptomatic until fragility fractures occur. These can be very destructive to a child or adolescent,and so, every effort shall be done to avoid them. Scan or densitometry is the most used method to confirm thediagnosis of PO. However its interpretation in the growing skeleton is not easy.PO treatment is a complex and contradictory issue, as there are no controlled, randomized studies. Preventionshould be the first choice, obtaining the maximum bone mass accrual through healthy life habits (optimalnutrition, exercise and sun exposure plans) and through the control of chronic diseases and restriction ofcorticosteroids.Along with calcium and vitamin D, biphosphonates are the most used drugs. Studies demonstrate thatbiphosphonates can be safe and effective in PO, but there is no consensus about dosis, duration of therapy andmonitoring adverse effects. Their use should be reserved to specialized and experienced centers.

Keywords: Osteoporosis; Child; Adolescent; Diagnosis; Therapy.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Costa HR, Ribeiro MM, Marques S, Castro H, Palhau L. Pediatric Osteoporosis: Revision of Diagnostic and Therapeutic Aspects. SPMFR [Internet]. 2013 Mar. 5 [cited 2024 Nov. 24];18(2):33-9. Available from: https://spmfrjournal.org/index.php/spmfr/article/view/50

Issue

Vol. 18 No. 2 (2009): Ano 17

Section

Review Article

License

Copyright statement

Authors must also submit a copyright statement (as seen below) on article submission.

To the Editor-in-chief of the SPMFR Journal:

The below signed author(s) hereby state that the article

________________________________________ (ref. MFR_________) is

an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.

By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.

Signed by all authors

Date:

Names (capital letters):

Signatures:

The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.